This protocol is judged by an institutional evaluate board, an unbiased team that evaluations any scientific trials involving humans. If a review includes a Program I drug, once the board approves the protocol as ethical, the researchers really need to submit an application for an investigational new drug (IND) number from the FDA.Together with the